Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

To cystoscope or not to cystoscope patients with traumatic spinal cord injuries managed with indwelling urethral or suprapubic catheters? That is the question!

El Masri y WS, Patil S, Prasanna KV, Chowdhury JR.

Spinal Cord. 2014 Jun;52(6):500. doi: 10.1038/sc.2014.37. Epub 2014 Apr 1. No abstract available.

PMID:
24686828
2.

To cystoscope or not to cystoscope patients with traumatic spinal cord injuries managed with indwelling urethral or suprapubic catheters? That is the question!

El Masri y WS, Patil S, Prasanna KV, Chowdhury JR.

Spinal Cord. 2014 Jan;52(1):49-53. doi: 10.1038/sc.2013.119. Epub 2013 Nov 26. Review.

PMID:
24276418
3.

A fourteen gene GBM prognostic signature identifies association of immune response pathway and mesenchymal subtype with high risk group.

Arimappamagan A, Somasundaram K, Thennarasu K, Peddagangannagari S, Srinivasan H, Shailaja BC, Samuel C, Patric IR, Shukla S, Thota B, Prasanna KV, Pandey P, Balasubramaniam A, Santosh V, Chandramouli BA, Hegde AS, Kondaiah P, Sathyanarayana Rao MR.

PLoS One. 2013 Apr 30;8(4):e62042. doi: 10.1371/journal.pone.0062042. Print 2013.

4.

Insulin growth factor-2 binding protein 3 (IGF2BP3) is a glioblastoma-specific marker that activates phosphatidylinositol 3-kinase/mitogen-activated protein kinase (PI3K/MAPK) pathways by modulating IGF-2.

Suvasini R, Shruti B, Thota B, Shinde SV, Friedmann-Morvinski D, Nawaz Z, Prasanna KV, Thennarasu K, Hegde AS, Arivazhagan A, Chandramouli BA, Santosh V, Somasundaram K.

J Biol Chem. 2011 Jul 22;286(29):25882-90. doi: 10.1074/jbc.M110.178012. Epub 2011 May 25.

5.

Unusual clinical and radiological presentation of metastatic choriocarcinoma to the brain and long-term remission following emergency craniotomy and adjuvant EMA-CO chemotherapy.

Dadlani R, Furtado SV, Ghosal N, Prasanna KV, Hegde AS.

J Cancer Res Ther. 2010 Oct-Dec;6(4):552-6. doi: 10.4103/0973-1482.77069.

6.

Proteomic identification of haptoglobin α2 as a glioblastoma serum biomarker: implications in cancer cell migration and tumor growth.

Kumar DM, Thota B, Shinde SV, Prasanna KV, Hegde AS, Arivazhagan A, Chandramouli BA, Santosh V, Somasundaram K.

J Proteome Res. 2010 Nov 5;9(11):5557-67. doi: 10.1021/pr1001737. Epub 2010 Sep 28.

PMID:
20822092
7.

Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.

Santosh V, Arivazhagan A, Sreekanthreddy P, Srinivasan H, Thota B, Srividya MR, Vrinda M, Sridevi S, Shailaja BC, Samuel C, Prasanna KV, Thennarasu K, Balasubramaniam A, Chandramouli BA, Hegde AS, Somasundaram K, Kondaiah P, Rao MR.

Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1399-408. doi: 10.1158/1055-9965.EPI-09-1213. Epub 2010 May 25.

Supplemental Content

Loading ...
Support Center